Clinical Trial Update: Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial update on PASCAL laser treatment for diabetic retinopathy, detailing changes in electroretinogram and contrast sensitivity; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Non Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy | Phase 4 | Status: TERMINATED